Acquisition | HARPOON THERAPEUTICS INC | 11th March 2024
Initially announced on January 8, 2024 MERCK & CO. INC. made a cash offer for HARPOON THERAPEUTICS INC of USD 23 per HARPOON THERAPEUTICS INC share held. The completion of the event is pending the approval of HARPOON THERAPEUTICS INC shareholders on March 8, 2024. Pending the completion of customary closing conditions, the Acquisition is expected to be completed on March 11, 2024. Trading in shares of HARPOON THERAPEUTICS INC is expected to be halted effective March 11, 2024.
The treatment below will be applied to the following indices:
- HARPOON THERAPEUTICS INC will be removed from the Index.
- The weight of HARPOON THERAPEUTICS INC (HARP.OQ) based on its last close price will be distributed pro rata to remaining Index constituents.
- Effective Date (open): 11/03/2024
Solactive Developed Markets Broad Healthcare EUR Index NTR
Solactive Developed Markets Broad Healthcare EUR Index PR
Solactive Developed Markets Broad Healthcare EUR Index TR
Solactive US Extended Broad Market Index (GTR)
Solactive United States 2500 Index NTR
Solactive United States 2500 Index
Solactive United States 2500 Index TR
Solactive United States 2000 EUR Index NTR
Solactive United States 2000 EUR Index
Solactive United States 2000 EUR Index TR
Solactive United States 2000 Index NTR
Solactive United States 2000 Index
Solactive United States 2000 Index TR
Solactive United States 3000 Index NTR
Solactive United States 3000 Index
Solactive United States 3000 Index TR